The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades-Reference-Cited by-同舟云学术

The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades

Published:2022-12 Issue: Volume:68 Page:104103
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Romero-Pinel Lucía^ORCID,Bau Laura,Matas Elisabet,León Isabel,Muñoz-Vendrell Albert,Arroyo Pablo,Masuet-Aumatell Cristina,Martínez-Yélamos Antonio,Martínez-Yélamos Sergio

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference43 articles.

1. Anticipation of age at onset in multiple sclerosis: methodologic pitfalls;Alonso-Magdalena;Acta Neurol. Scand.,2010

2. Pediatric multiple sclerosis: a review;Alroughani;BMC Neurol.,2018

3. Age-Specific prevalence of Epstein-Barr virus infection among individuals aged 6–19 years in the United States and factors affecting its acquisition;Balfour;J. Infect. Dis.,2013

4. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis;Bjornevik;Science,2022

5. Does the changing sex ratio of multiple sclerosis give opportunities for intervention?;Boström;Acta Neurol. Scand.,2015

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Demographic Inaccuracies and Biases in the Depiction of Patients by Artificial Intelligence Text-to-Image Generators;2024-07-25

2. Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis;Journal of Neurology;2024-07-03

3. Self-reported cognitive function mediates the relationship between employment status and cognitive functioning in persons with multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-07

4. Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system;Frontiers in Neurology;2024-06-27

5. Disease-modifying therapies as positive predictors of quality of life for Sudanese patients with multiple sclerosis: a cross-sectional study;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2024-06-20